Avalo Therapeutics AVTX 深 沪
等待开盘 10-07 09:30:00 美东时间
13.645
-0.955
-6.54%
华盛通- 最 高20.94
- 今 开14.58
- 成交量 32.87万股
- 最 低 13.51
- 昨 收 14.60
- 总市值 154.19万
- 52周最高 24.27
- 市盈率 静 --
- 换手率 290.86%
- 52周最低 12.51
- 委 比 47.51%
- 总股本 0.00亿
- 历史最高 22032.00
- 量 比 0.75
- 振 幅 50.89%
- 历史最低 3.39
- 每 手 1
- 风险率 2.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Avalo Therapeutics To Present Abdakibart Data At EADV Congress 2026
Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced a late-breaker
09-23 19:07
This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Wall Street analysts upgraded EDU, MKTX, and FORM stocks. Check out their ratings on Benzinga's analyst ratings page before buying EDU.
06-12 21:06
Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results
Avalo Therapeutics Inc (NASDAQ:AVTX) shares are surging after the company delivered a major clinical win, strengthened its balance sheet with a new offering and picked up fresh support from Wall Street analysts.
05-07 02:09
Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why
Avalo Therapeutics Inc. rises sharply in pre-market trading following a Phase 2 trial win and a $375 million offering.
05-06 16:44
BTIG Reiterates Buy on Avalo Therapeutics, Maintains $40 Price Target
BTIG analyst Julian Harrison reiterates Avalo Therapeutics (NASDAQ:AVTX) with a Buy and maintains $40 price target.
03-24 17:57
Earnings Scheduled For March 23, 2026
Companies Reporting Before The Bell • Avalo Therapeutics (NASDAQ:AVTX) is likel...
03-23 19:11
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
Avalo Therapeutics appoints Rita Jain, M.D., to its Board of Directors, enhancing its leadership in advancing AVTX-009, a Phase 2 anti-IL-1β antibody for hidradenitis suppurativa and other inflammatory diseases.
2025-06-18 11:00
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
<p>Study highlights that AVITA Medical's RECELL technology reduces hospital stays and costs for burn patients, offering a more efficient and less painful alternative to traditional skin grafts.</p>
2025-06-09 13:00
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Avalo Therapeutics announced that its management will participate in two investor conferences in June: the Jefferies Global Healthcare Conference on June 4 and the Oppenheimer Innovators in I&I Summit on June 25. The company focuses on treating immune dysregulation, with its lead asset being AVTX-009, an anti-IL-1β monoclonal antibody targeting inflammatory diseases.
2025-05-27 14:05
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM). Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in tod...
2024-09-04 01:41
